Search Browse Earnings

ADC Therapeutics SA — SlamSEC

ADC Therapeutics SA

NYSE:ADCT

Pharmaceutical Preparations·EPALINGES, V8

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$74.9M

FY 2023

Adj. EBITDA

-$164.8M

-220.0% margin

FY 2024

Net Income

-$240.1M

-320.5% margin

FY 2024

EPS (Diluted)

-$2.94

FY 2024

Stock Price

$4.23

+2.9%

2026-03-09

52W Range

$1.05 – $4.80

P/E Ratio

-1.4x

Market Cap

$524.0M

Cash

$278.6M

FY 2024

Total Debt

—

Net Cash

$278.6M

FY 2023

Enterprise Value

$245.4M

Debt / EBITDA

1.7x

FY 2023

EV / EBITDA

-1.5x

Employees

—

CEO

Mallik Ameet

CFO

Carmona Jose